This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
Regulus Therapeutics Inc
RGLS : NASDAQ : Health Care
$6.82 0.19 | 2.87%
Today's Range: 6.56 - 7.20
Avg. Daily Volume: 63,600
10/20/14 - 4:00 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
RGLS REGULUS THERAPEUTICS INC 6.92 300.27 n/m 13.94 -0.75
GERN GERON CORP 2.20 345.14 n/m 1.22 -44.56
CTIC CTI BIOPHARMA CORP 2.28 342.34 n/m 36.00 2413.96
PGNX PROGENICS PHARMACEUTICAL INC 4.85 337.35 n/m 7.13 -49.20
EXEL EXELIXIS INC 1.62 316.08 n/m 21.28 -50.11
SVA SINOVAC BIOTECH LTD 5.52 307.45 55.20 70.66 15.10
AMBI AMBIT BIOSCIENCES CORP 15.55 279.93 n/m 9.01 -64.48
PPHM PEREGRINE PHARMACEUTICLS INC 1.44 276.78 n/m 23.21 4.92
CUR NEURALSTEM INC 3.11 270.06 n/m 0.01 -94.99
RTRX RETROPHIN INC 9.98 266.29 n/m 5.77 n/a
ZIOP ZIOPHARM ONCOLOGY INC 2.59 260.92 n/m 0.80 0.00
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

RGLS Ind Avg S&P 500
n/m 79.53 18.06

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Top Rated Stocks Top Rated Funds Top Rated ETFs